𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Appropriateness of therapy for fistulizing Crohn’s disease: findings from a national inflammatory bowel disease cohort

✍ Scribed by V. Pittet; P. Juillerat; P. Michetti; J.-P. Vader; B. Burnand; G. Rogler; C. Beglinger; F. Seibold; C. Mottet; C. Felley; J.-J. Gonvers; F. Froehlich; The Swiss IBD Cohort Study Group

Book ID
108606056
Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
177 KB
Volume
32
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Frequency, phenotype, outcome, and thera
Frequency, phenotype, outcome, and therapeutic impact of skin reactions following initiation of adalimumab therapy: Experience from a consecutive cohort of inflammatory bowel disease patients
✍ Daniel C. Baumgart; Ulrike Grittner; Andrea Steingräber; Marina Azzaro; Sandra P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

## Background: The monoclonal anti tumor necrosis factor (TNF) antibody adalimumab has recently been approved for Crohn's disease (CD) and evaluated for ulcerative colitis (UC). Cutaneous lesions associated with its administration have not been prospectively studied in inflammatory bowel disease (